Login to Your Account



Pharma: Other News To Note


Wednesday, October 10, 2012
• Foundation Medicine Inc., of Cambridge, Mass., signed a multiyear agreement with Eisai Co. Ltd., of Tokyo, for genomic profiling and diagnostic discovery in a multisite, international clinical trial testing an Eisai therapeutic candidate.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription